問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Medical University Hospital (在職)

Division of Rheumatology

更新時間:2023-09-19

邱啟勝Chiou, Chi-Sheng
  • Co-Principal Investigator
  • Clinical Trial Experience (year) 12 years 9 個月

篩選

List

2Cases

2013-05-28 - 2016-09-21

Phase III

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Blisibimod Administration in Subjects with Systemic Lupus Erythematosus
  • Condition/Disease

    Systemic Lupus Erythematosus

  • Test Drug

    Blisibimod

Participate Sites
5Sites

Terminated4Sites

Study ended1Sites

2015-04-01 - 2017-03-31

Phase I/II

  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Terminated4Sites